Fabry disease: diagnosis of a rare disorder / Doença de fabry: diagnóstico de uma doença rara
Rev. HCPA & Fac. Med. Univ. Fed. Rio Gd. do Sul
;
26(3): 111-114, 2006.
Article
Dans Anglais
| LILACS
| ID: lil-691663
ABSTRACT
Fabry disease (FD) is an X-linked inborn error of glycosphingolipid metabolism due to thedeficiency of α-galactosidase A. The progressive accumulation of globotriaosylceramide (Gb3),particularly in the vascular endothelium, leads to renal, cardiac, and cerebrovascularmanifestations and early death. Clinical manifestations include the onset of pain and paresthesiasin extremities, angiokeratoma and hypohidrosis during childhood or adolescence. Proteinuriaand lymphedema occur with increasing age. Severe renal impairment leads to hypertension anduremia. Death usually occurs due to renal failure or cardiac or cerebrovascular disease. Diseasepresentation may be subtle, and its signs and symptoms are often discounted as malingering orare mistakenly attributed to other disorders, such as rheumatic fever, neurosis, multiple sclerosis,lupus, or petechiae.We present a 46-year-old man who since adolescence has suffered from painfulacroparesthesia, disseminated skin angiokeratomas, hypohidrosis and heat intolerance. He wassubmitted to a thorough investigation with different specialists, but never reached a diagnosis.He started hemodialysis 3 years ago and at the moment is in standby for kidney transplantation.He was enrolled in a Brazilian FD screening and a reduced serum activity of α-galactosidase A(0.0027 nmol/h/mL reference value 4-22) confirmed the diagnosis of FD.He has angiokeratoma at the bottom area, his echocardiogram demonstrated left ventricularhypertrophy and the family history is very rich, as the patient has 15 siblings.
RESUMO
A doença de Fabry (DF) é um erro inato do metabolismo dos glicoesfingolipídeos devido àdeficiência da α-galactosidase A. O acúmulo progressivo de globotriaosilceramida (Gb3), particularmente no endotélio vascular, leva a manifestações renais, cardíacas e cerebrovascularese morte precoce. As manifestações clínicas incluem o início, durante a infância ou adolescência,de episódios de dor e parestesias nas extremidades, angioqueratomas e hipohidrose. Com aidade, podem aparecer proteinúria e linfedema. Insuficiência renal grave leva à hipertensão euremia. O óbito ocorre devido à insuficiência renal ou doença cardíaca ou cerebrovascular. Aapresentação da doença pode ser sutil, e seus sinais e sintomas são erroneamente atribuídosa outras doenças, como febre reumática, neurose, esclerose múltipla, lúpus ou petéquias.Relatamos o caso de um paciente masculino com 46 anos que, desde a adolescência,sofre de acroparestesia, angioqueratomas disseminados, hipohidrose e intolerância ao calor.
Recherche sur Google
Indice:
LILAS (Amériques)
Sujet Principal:
Maladie de Fabry
/
Thérapie enzymatique substitutive
/
Défaillance rénale chronique
/
Lysosomes
Type d'étude:
Etude diagnostique
/
Étude pronostique
/
Étude de dépistage
langue:
Anglais
Texte intégral:
Rev. HCPA & Fac. Med. Univ. Fed. Rio Gd. do Sul
Thème du journal:
Médicament
Année:
2006
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Hospital de Clínicas de Porto Alegre/BR
/
Universidade Federal do Rio Grande do Sul/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS